Investors and Media

Scientific presentations

Scientific presentations and posters

Below are several selected presentations and posters which can be downloaded as PDFs.

Duchenne Muscular Dystrophy (DMD)

2019 Muscular Dystrophy Association (MDA) Clinical and Scientific Conference (Orlando, USA)
April 13-17, 2019.
Poster #7: SYROS study – long-term reduction in rate of respiratory function decline in patients with Duchenne Muscular Dystrophy (DMD) treated with idebenone
Poster #9: Consistent long-term effect of idebenone in reducing respiratory function decline in advanced patients with Duchenne Muscular Dystrophy (DMD)
Poster #11: Crossing thresholds and changing rates of respiratory function decline are predictive of clinical outcomes in Duchenne Muscular Dystrophy (DMD)

23rd International Congress of the World Muscle Society - WMS (Mendoza, Argentina)
October 2-6, 2018. Scientific poster presentations.

15th International Congress on Neuromuscular Diseases - ICNMD (Vienna, Austria)
July 6-10, 2018. Scientific poster presentations.

2018 Parent Project Muscular Dystrophy Annual Conference (Scottsdale, Arizona, USA)
June 28-30, 2018. Presentation by Kristina Sjöblom Nygren, CMO

16th International Conference on Duchenne and Becker Muscular Dystrophy (Rome, Italy)
February 16-18, 2018. Referat von Thomas Meier, CEO

American Thoracic Society 113th Annual Conference (Washington, DC)
May 22-23, 2017.
Scientific poster: Correlation between volume- and flow-related pulmonary function outcomes in patients with DMD
Scientific poster: Effect of Idebenone on Bronchopulmonary Adverse Events and Hospitalizations in Patients with Duchenne Muscular Dystrophy (DMD)

Leber's Hereditary Optic Neuropathy (LHON)

EUNOS - 14th Meeting of European Neuro-Ophthalmological Society (Porto, Portugal)
June 16-19, 2019.
Poster P052: Long-term (over 24 months) treatment with idebenone may continue to improve visual function response in patients with Leber’s Hereditary Optic Neuropathy (LHON)
Poster P053: Responder analysis of chronic Leber’s hereditary optic neuropathy (LHON) patients to idebenone in a placebo controlled, randomized clinical trial (RHODOS)
Poster P054: Pediatric Leber’s Hereditary Optic Neuropathy (LHON): Real-world efficacy results following long term idebenone treatment
Poster P055: Evaluating long-term real-world data (RWD) from patients with Leber’s hereditary optic neuropathy (LHON) in light of the recommendations of the International Consensus statement
Poster PAG: A Patient Centric Activity in the Development and Lifecycle of Medicines

NANOS - 45th Annual Meeting of the North-American Neuro-Ophthalmology Society (Las Vegas, USA)
March 16-21, 2019. Scientific poster presentations.

ARVO - Annual Meeting of The Association for Research in Vision and Ophthalmology (Seattle, USA)
May 4, 2016. Poster presentation by Shabir Hasham: Treatment of visual impairment in patients with Leber’s hereditary optic neuropathy using idebenone (Raxone®)

EUNOS - 12th Meeting of European Neuro-Ophthalmological Society (Ljubljana, Slovenia)
June 24, 2015. Presentation by Günther Metz: Clinical experience with idebenone (Raxone®) in the treatment of patients with Leber’s hereditary optic neuropathy

EVER - Annual Meeting of The European Association for Vision and Eye Research (Nice; France)
October 8, 2015. Poster presentation by Claudia Catarino: Clinical experience with idebenone (Raxone®) in the treatment of patients with Leber’s hereditary optic neuropathy (LHON)

Cystic Fibrosis (CF)

Annual North American Cystic Fibrosis Conference - Denver, CO, USA
October 18-20, 2018. Scientific poster: Results From Two Completed Phase I Studies With POL6014-A Novel Inhaled Neutrophil Elastase Inhibitor